Accès ouvert · CC BY

Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis

Article scientifique 2018 Sciences de la santé Anglais

Résumé

The Leishmania parasite resides and replicates within host macrophages during visceral leishmaniasis (VL). This study aimed to evaluate neopterin, a marker of macrophage activation, as possible pharmacodynamic biomarker to monitor VL treatment response and to predict long-term clinical relapse of VL. Following informed consent, 497 plasma samples were collected from East-African VL patients receiving a 28-day miltefosine monotherapy (48 patients) or 11-day combination therapy of miltefosine and liposomal amphotericin B (L-AMB, 48 patients). Neopterin was quantified with ELISA. Values are reported as median (inter-quartile range). Baseline neopterin concentrations were elevated in all VL patients at 98.8 (63.9-135) nmol/L compared to reported levels for healthy controls (<10 nmol/L). During the first treatment week, concentrations remained stable in monotherapy patients (p=0.807), but decreased two-fold compared to baseline in the combination therapy patients (p<0.01). In the combination therapy arm, neopterin concentrations increased significantly one day after L-AMB infusion compared to baseline for cured patients (137 (98.5-197) nmol/L, p<0.01), but not for relapsing patients (84.4 (68.9-106) nmol/L, p=0.96). The neopterin parameter with the highest predictive power for VL relapse was a higher than 8% neopterin concentration increase between end of treatment and day 60 follow-up (ROC AUC 0.84), with a 93% sensitivity and 65% specificity. In conclusion, the identified neopterin parameter could be a potentially useful surrogate endpoint to identify patients in clinical trials at risk of relapse earlier during follow-up, possibly in a panel of biomarkers to increase its specificity.

Citer ce document

Kip, A. E., Wasunna, M., Alves, F., Schellens, J. H., Beijnen, J. H., Musa, A., Khalil, E. A. G., & Dorlo, T. P. C. (2018). Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2018.00181

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 30/08/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 13

Téléchargements (hors robots) : 0

Méthode de comptage